Purification and characterization of a β-glucosidase from Streptomyces lividans 66

1990 ◽  
Vol 36 (1) ◽  
pp. 53-56 ◽  
Author(s):  
Anca Mihoc ◽  
Dieter Kluepfel
Keyword(s):  
High Performance Liquid Chromatography ◽  
Molecular Sieve ◽  
Type Strain ◽  
High Performance ◽  
Wild Type Strain ◽  
Streptomyces Lividans ◽  
Wild Type ◽  
Purification And Characterization ◽  
Anion Exchange Column

An intracellular β-1, 4-D-glucosidase (EC 3.2.1.21) was isolated from the mutant strain HP-3 of Streptomyces lividans 66 which produced about 12 times more enzyme than the wild-type strain. The purification was carried out by anion exchange column chromatography followed by high-performance liquid chromatography on DEAE and on molecular sieve columns. The enzyme is glycosylated and has an apparent Mr of 51 000 and a pI of 4.3. Its activity was optimal at pH 6.5 and at a temperature of 40 °C. The Km and the Vmax on cellobiose were 3.1 mM and 65.6 μmol min−1 mg−1 of enzyme. Key words: β-glucosidase, Streptomyces lividans, purification, characterization.

scholarly journals Characterization of a Wild-Type Strain ofFrancisella TularensisIsolated from a Cat

2004 ◽  
Vol 16 (5) ◽  
pp. 374-381 ◽  
Author(s):  
Thomas J. Inzana ◽  
Gretchen E. Glindemann ◽  
Gerald Snider ◽  
Susan Gardner ◽  
Lisa Crofton ◽  
...  
Keyword(s):  
Type Strain ◽  
Wild Type Strain ◽  
Wild Type

scholarly journals Regulation of ppk Expression and In Vivo Function of Ppk in Streptomyces lividans TK24

2006 ◽  
Vol 188 (17) ◽  
pp. 6269-6276 ◽  
Author(s):  
Sofiane Ghorbel ◽  
Aleksey Smirnov ◽  
Hichem Chouayekh ◽  
Brice Sperandio ◽  
Catherine Esnault ◽  
...  
Keyword(s):  
Mutant Strain ◽  
Type Strain ◽  
Wild Type Strain ◽  
Sufficient Conditions ◽  
Streptomyces Lividans ◽  
Antibiotic Biosynthesis ◽  
Wild Type ◽  
In The Wild

ABSTRACT The ppk gene of Streptomyces lividans encodes an enzyme catalyzing, in vitro, the reversible polymerization of the γ phosphate of ATP into polyphosphate and was previously shown to play a negative role in the control of antibiotic biosynthesis (H. Chouayekh and M. J. Virolle, Mol. Microbiol. 43:919-930, 2002). In the present work, some regulatory features of the expression of ppk were established and the polyphosphate content of S. lividans TK24 and the ppk mutant was determined. In Pi sufficiency, the expression of ppk was shown to be low but detectable. DNA gel shift experiments suggested that ppk expression might be controlled by a repressor using ATP as a corepressor. Under these conditions, short acid-soluble polyphosphates accumulated upon entry into the stationary phase in the wild-type strain but not in the ppk mutant strain. The expression of ppk under Pi-limiting conditions was shown to be much higher than that under Pi-sufficient conditions and was under positive control of the two-component system PhoR/PhoP. Under these conditions, the polyphosphate content of the cell was low and polyphosphates were reproducibly found to be longer and more abundant in the ppk mutant strain than in the wild-type strain, suggesting that Ppk might act as a nucleoside diphosphate kinase. In light of our results, a novel view of the role of this enzyme in the regulation of antibiotic biosynthesis in S. lividans TK24 is proposed.

scholarly journals Regulation and Characterization of a Newly Deduced Cell Wall Hydrolase Gene (cwlJ) Which Affects Germination of Bacillus subtilis Spores

1998 ◽  
Vol 180 (6) ◽  
pp. 1375-1380 ◽  
Author(s):  
Shu Ishikawa ◽  
Kunio Yamane ◽  
Junichi Sekiguchi
Keyword(s):  
Bacillus Subtilis ◽  
Type Strain ◽  
Wild Type Strain ◽  
Catalytic Domain ◽  
Slow Release ◽  
Dipicolinic Acid ◽  
Northern Hybridization ◽  
Predicted Amino Acid Sequence ◽  
Wild Type

ABSTRACT The predicted amino acid sequence of Bacillus subtilis ycbQ (renamed cwlJ) exhibits high similarity to those of the deduced C-terminal catalytic domain of SleBs, the specific cortex-hydrolyzing enzyme of B. cereus and the deduced one of B. subtilis. We constructed acwlJ::lacZ fusion in the B. subtilischromosome. The β-galactosidase activity and results of Northern hybridization and primer extension analyses of the cwlJgene indicated that it is transcribed by EςE RNA polymerase. cwlJ-deficient spores responded to bothl-alanine and AGFK, the A 580 values of spore suspensions decreased more slowly than in the case of the wild-type strain, and the mutant spores released less dipicolinic acid than did those of the wild-type strain during germination. However, the mutant spores released only slightly less hexosamine than did the wild-type spores. In contrast, B. subtilis sleB spores did not release hexosamine at a significant level. While cwlJand sleB spores were able to germinate, CJSB (cwlJ sleB) spores could not germinate but exhibited initial germination reactions, e.g., partial decrease inA 580 and slow release of dipicolinic acid. CJSB spores became slightly gray after 6 h in the germinant, but their refractility was much greater than that of sleB mutant spores. The roles of the sleB and cwlJmutations in germination and spore maturation are also discussed.

scholarly journals Characterization of melanin produced by a wild-type strain of Bacillus thuringiensis

2004 ◽  
Vol 50 (4) ◽  
pp. 183-188 ◽  
Author(s):  
Yuehua Chen ◽  
Yinyue Deng ◽  
Jinhong Wang ◽  
Jun Cai ◽  
Gaixin Ren
Keyword(s):  
Bacillus Thuringiensis ◽  
Type Strain ◽  
Wild Type Strain ◽  
Wild Type

scholarly journals Characterization of emeA, anorA Homolog and Multidrug Resistance Efflux Pump, inEnterococcus faecalis

2001 ◽  
Vol 45 (12) ◽  
pp. 3574-3579 ◽  
Author(s):  
Brandie M. Jonas ◽  
Barbara E. Murray ◽  
George M. Weinstock
Keyword(s):  
Drug Resistance ◽  
Multidrug Resistance ◽  
Type Strain ◽  
Deletion Mutant ◽  
Wild Type Strain ◽  
Efflux Pump ◽  
Wild Type ◽  
Type Gene ◽  
Encoding Genes

ABSTRACT We hypothesized that multidrug resistance efflux pumps (MDRs) may be contributing to the drug resistance of enterococci. We recently identified potential MDR-encoding genes in the Enterococcus faecalis V583 genome. Among the putative MDRs, we found a gene that encodes a NorA homolog and have characterized this enterococcal MDR in the present study. A mutant from which the enterococcal NorA homolog has been deleted has reduced resistance to several NorA substrates. Complementation of the deletion mutant with the wild-type gene verified the involvement of this enterococcal gene in resistance to ethidium bromide (EtBr) and norfloxacin. Known MDR inhibitors (reserpine, lansoprazole, and verapamil) inhibit the efflux of EtBr and norfloxacin in wild-type strain OG1RF. A fluorescence assay with EtBr allowed us to quantitate the efflux capability of the enterococcal NorA pump. On the basis of these results, we have named this enterococcal gene emeA (enterococcal multidrug resistance efflux).

scholarly journals Characterization of Human Bactericidal Antibodies to Bordetella pertussis

1999 ◽  
Vol 67 (3) ◽  
pp. 1424-1431 ◽  
Author(s):  
Alison A. Weiss ◽  
Paula S. Mobberley ◽  
Rachel C. Fernandez ◽  
ChrisAnna M. Mink
Keyword(s):  
Immune Response ◽  
Bactericidal Activity ◽  
Bordetella Pertussis ◽  
Type Strain ◽  
Wild Type Strain ◽  
Resistance Mechanism ◽  
Wild Type ◽  
Occupationally Exposed ◽  
Bactericidal Activities

ABSTRACT The Bordetella pertussis BrkA protein protects against the bactericidal activity of complement and antibody; however, some individuals mount an immune response that overcomes this bacterial defense. To further characterize this process, the bactericidal activities of sera from 13 adults with different modes of exposure toB. pertussis (infected as adults, occupational exposure, immunized with an acellular vaccine, or no identified exposure) against a wild-type strain and a BrkA complement-sensitive mutant were evaluated. All of the sera killed the BrkA mutant, suggesting past exposure to B. pertussis or cross-reactive organisms. Several samples had no or minimal activity against the wild type. All of the sera collected from the infected and occupationally exposed individuals but not all of the sera from vaccinated individuals had bactericidal activity against the wild-type strain, suggesting that some types of exposure can induce an immune response that can overcome the BrkA resistance mechanism. Adsorbing serum with the wild-type strain removed the bactericidal antibodies; however, adsorbing the serum with a lipopolysaccharide (LPS) mutant or an avirulent (bvg mutant) strain did not always result in loss of bactericidal activity, suggesting that antibodies to either LPS orbvg-regulated proteins could be bactericidal. All the samples, including those that lacked bactericidal activity, contained antibodies that recognized the LPS of B. pertussis. Bactericidal activity correlated best with the presence of the immunoglobulin G3 (IgG3) antibodies to LPS, the IgG subtype that is most effective at fixing complement.

scholarly journals Mutagenesis by Insertion of Tn4001 into the Genome of Spiroplasma citri: Characterization of Mutants Affected in Plant Pathogenicity and Transmission to the Plant by the Leafhopper Vector Circulifer haematoceps

1997 ◽  
Vol 10 (4) ◽  
pp. 454-461 ◽  
Author(s):  
X. Foissac ◽  
J. L. Danet ◽  
C. Saillard ◽  
P. Gaurivaud ◽  
F. Laigret ◽  
...  
Keyword(s):  
Type Strain ◽  
Culture Medium ◽  
Wild Type Strain ◽  
Single Copy ◽  
Wild Type ◽  
Spiroplasma Citri ◽  
Leafhopper Vector ◽  
Circulifer Haematoceps ◽  
Plant Pathogenicity

Two hundred and fifty-seven transposon Tn4001 mutants of Spiroplasma citri strain GII3 were used for transmission assays by the leafhopper vector Circulifer haematoceps into periwinkle (Catharanthus roseus) plants. Multiplication of the mutants in the two hosts, the leafhopper and the plant, as well as the symptom expression in the plant were studied. Two mutants, GMT 470 and GMT 553, caused no symptoms on plants. Tn4001 is inserted as a single copy in the genome of these mutants. Mutant GMT 470 did not multiply, or multiplied only poorly, in the leaf-hopper and was not transmitted by the insect to the plant, nor to culture medium through Parafilm membrane. The growth rate of GMT 470 in SP4 medium was twice as slow as that of wild-type strain GII3. Mutant GMT 553 multiplied in the leafhopper as well as the wild-type spiro-plasma, and was transmitted by the leafhoppers into the plants, where it reached the same titers as the wild-type strain but in approximately twice as much time. The plants containing high titers of mutant GMT 553 remained symptomless for several weeks. However, symptoms began to develop at a time when revertants that had lost the transposon were detected.

scholarly journals Mutants of Streptomyces clavuligerus with Disruptions in Different Genes for Clavulanic Acid Biosynthesis Produce Large Amounts of Holomycin: Possible Cross-Regulation of Two Unrelated Secondary Metabolic Pathways

2002 ◽  
Vol 184 (23) ◽  
pp. 6559-6565 ◽  
Author(s):  
Alvaro de la Fuente ◽  
Luis M. Lorenzana ◽  
Juan F. Martín ◽  
Paloma Liras
Keyword(s):  
Clavulanic Acid ◽  
Type Strain ◽  
High Performance ◽  
Wild Type Strain ◽  
Regulatory Gene ◽  
Bioactive Compound ◽  
Streptomyces Clavuligerus ◽  
Wild Type ◽  
Reading Frame ◽  
Acid Pathway

ABSTRACT A Streptomyces clavuligerus ccaR::aph strain, which has a disruption in the regulatory gene ccaR, does not produce cephamycin C or clavulanic acid, but does produce a bioactive compound that was identified as holomycin by high-performance liquid chromatography (HPLC) and infrared and mass spectrometry. S. clavuligerus strains with disruptions in different genes of the clavulanic acid pathway fall into three groups with respect to holomycin biosynthesis. (i) Mutants with mutations in the early steps of the pathway blocked in the gene ceaS (pyc) (encoding carboxyethylarginine synthase), bls (encoding a β-lactam synthetase), or open reading frame 6 (ORF6; coding for an acetyltransferase of unknown function) are holomycin nonproducers. (ii) Mutants blocked in the regulatory gene ccaR or claR or blocked in the last gene of the pathway encoding clavulanic acid reductase (car) produce holomycin at higher levels than the wild-type strain. (iii) Mutants with disruption in cyp (coding for cytochrome P450), ORF12, and ORF15, genes that appear to be involved in the conversion of clavaminic acid into clavaldehyde or in secretion steps, produce up to 250-fold as much holomycin as the wild-type strain. An assay for holomycin synthetase was developed. This enzyme forms holomycin from holothin by using acetyl coenzyme A as an acetyl group donor. The holomycin synthase activities in the different clavulanic acid mutants correlate well with their production of holomycin.

Sign in / Sign up

Export Citation Format

Share Document